Literature DB >> 2730120

Immunological evaluation in the early diagnosis of prenatal or perinatal HIV infection.

D Nadal1, U A Hunziker, J Schüpbach, J C Wetzel, Z Tomasik, J B Jendis, A Fanconi, R A Seger.   

Abstract

A longitudinal evaluation was carried out of the clinical, infective, and immunological progress of 34 children (who were aged 6 to 68 months--mean 25 months at the time of writing) born to 31 mothers infected with human immunodeficiency virus (HIV), over a mean observation period of 13.4 months. Clinical symptoms, not always clearly related to HIV became apparent in 11 children, and preceding immune abnormalities were documented in two of them. In eight children culture for HIV was positive, and six of these were symptomatic. No cancers were diagnosed and none of the children died. Immune abnormalities including hypergammaglobulinaemia, IgG subclass deficiency, low serum IgA concentration, antibody deficiency, a decrease in the number of CD4+(T helper) cells, and defective cellular responses to antigens, were found in seven of the children in whom culture for HIV was positive; in two of four who had symptoms and in all four who were symptom free and in whom culture was negative for HIV but in whom HIV antibodies persisted and who were older than 15 months; and in three of nine who were symptom free and in whom culture was negative with loss of HIV antibodies. We conclude that serological diagnosis alone may be misleading and that additional immunological assessment may help to identify affected children. Analysis of humoral and cellular responses to antigens used for vaccination such as tetanus toxoid by measurement of specific antibodies and skin testing are simple and helpful in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2730120      PMCID: PMC1792037          DOI: 10.1136/adc.64.5.662

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  9 in total

1.  Pediatric acquired immunodeficiency syndrome. Neurologic syndromes.

Authors:  A L Belman; G Diamond; D Dickson; D Horoupian; J Llena; G Lantos; A Rubinstein
Journal:  Am J Dis Child       Date:  1988-01

2.  Delayed appearance of HIV infection in children.

Authors:  F Aiuti; G Luzi; I Mezzaroma; G Scano; C Papetti
Journal:  Lancet       Date:  1987-10-10       Impact factor: 79.321

3.  Longitudinal study of 18 children with perinatal LAV/HTLV III infection: attempt at prognostic evaluation.

Authors:  S Blanche; F Le Deist; A Fischer; F Veber; M Debre; S Chamaret; L Montagnier; C Griscelli
Journal:  J Pediatr       Date:  1986-12       Impact factor: 4.406

4.  Restoration of suppressor T-cell functions in children with AIDS following intravenous gamma globulin treatment.

Authors:  A Gupta; B E Novick; A Rubinstein
Journal:  Am J Dis Child       Date:  1986-02

5.  Evaluation of diagnostic tests for HIV infection in infants born to HIV-infected mothers in Switzerland.

Authors:  J B Jendis; Z Tomasik; U Hunziker; D Nadal; R Seger; J C Wetzel; C Kind; J Schüpbach
Journal:  AIDS       Date:  1988-08       Impact factor: 4.177

6.  In-vitro production of HIV-specific antibody in children at risk of AIDS.

Authors:  A Amadori; A de Rossi; C Giaquinto; G Faulkner-Valle; F Zacchello; L Chieco-Bianchi
Journal:  Lancet       Date:  1988-04-16       Impact factor: 79.321

7.  Defective humoral immunity in pediatric acquired immune deficiency syndrome.

Authors:  L J Bernstein; H D Ochs; R J Wedgwood; A Rubinstein
Journal:  J Pediatr       Date:  1985-09       Impact factor: 4.406

8.  Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma.

Authors:  B J Poiesz; F W Ruscetti; A F Gazdar; P A Bunn; J D Minna; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1980-12       Impact factor: 11.205

9.  Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

Authors:  M Popovic; M G Sarngadharan; E Read; R C Gallo
Journal:  Science       Date:  1984-05-04       Impact factor: 47.728

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.